NCT01169337 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 90
- group Id
- BG002
- value
- 92
- group Id
- BG003
- value
- 226
- units
- Participants
- groups
- description
- Patients receive lenalidomide PO QD on days 1-21. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG000
- title
- Arm A (Lenalidomide; Phase II)
- description
- Patients receive lenalidomide PO QD on days 1-21. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG001
- title
- Arm A (Lenalidomide; Phase III)
- description
- Patients undergo observation until progression to symptomatic myeloma.
- id
- BG002
- title
- Arm B (Observation; Phase III)
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 36
- upper Limit
- 83
- value
- 62
- group Id
- BG001
- lower Limit
- 31
- upper Limit
- 82
- value
- 63
- group Id
- BG002
- lower Limit
- 33
- upper Limit
- 96
- value
- 64
- group Id
- BG003
- lower Limit
- 31
- upper Limit
- 86
- value
- 64
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 48
- group Id
- BG002
- value
- 46
- group Id
- BG003
- value
- 118
- title
- Female
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 46
- group Id
- BG003
- value
- 108
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 81
- group Id
- BG002
- value
- 81
- group Id
- BG003
- value
- 205
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 15
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 37
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 72
- group Id
- BG002
- value
- 68
- group Id
- BG003
- value
- 177
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 10
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- All registered patients in phase II portion and randomized patients in phase III portion
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 90
- group Id
- BG002
- value
- 92
- group Id
- BG003
- value
- 226
- units
- Participants
- groups
- description
- Patients receive lenalidomide PO QD on days 1-21. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG000
- title
- Arm A (Lenalidomide; Phase II)
- description
- Patients receive lenalidomide PO QD on days 1-21. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG001
- title
- Arm A (Lenalidomide; Phase III)
- description
- Patients undergo observation until progression to symptomatic myeloma.
- id
- BG002
- title
- Arm B (Observation; Phase III)
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 36
- upper Limit
- 83
- value
- 62
- group Id
- BG001
- lower Limit
- 31
- upper Limit
- 82
- value
- 63
- group Id
- BG002
- lower Limit
- 33
- upper Limit
- 96
- value
- 64
- group Id
- BG003
- lower Limit
- 31
- upper Limit
- 86
- value
- 64
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 48
- group Id
- BG002
- value
- 46
- group Id
- BG003
- value
- 118
- title
- Female
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 46
- group Id
- BG003
- value
- 108
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 81
- group Id
- BG002
- value
- 81
- group Id
- BG003
- value
- 205
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 15
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 37
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 72
- group Id
- BG002
- value
- 68
- group Id
- BG003
- value
- 177
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 10
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- All registered patients in phase II portion and randomized patients in phase III portion
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle